Abstract
Myocardial infarction remains the leading cause of death worldwide despite an improvement in outcomes over the last several decades (Reed et. al., 2017). Although primary prevention of cardiovascular disease through pharmacological measures has been a key part of this progress, many patients have comorbidities that independently increase their cardiovascular risk. In their linked article, “Association of S100A8/A9 with lipid-rich necrotic core (LRNC) and treatment with biologic therapy in patients with psoriasis: results from an observational cohort study” (Berg et al., 2022), the authors present data to further elucidate the complex relationship between psoriasis and cardiovascular health.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
